Search

Your search keyword '"Baasanjav B."' showing total 37 results

Search Constraints

Start Over You searched for: Author "Baasanjav B." Remove constraint Author: "Baasanjav B."
37 results on '"Baasanjav B."'

Search Results

3. Prevalence, associated factors and outcomes of pressure injuries in adult intensive care unit patients: the DecubICUs study

4. Sphingosine kinase 2 and p62 regulation are determinants of sexual dimorphism in hepatocellular carcinoma.

5. Comprehensive metabolic modulations of sphingolipids are promising severity indicators in COVID-19.

6. Alzheimer's disease manifests abnormal sphingolipid metabolism.

7. Development of an advanced liquid chromatography-tandem mass spectrometry measurement system for simultaneous sphingolipid analysis.

8. Cerebrospinal Fluid Lysophosphatidylcholine Species for Distinguishing Narrowing of the Lumbar Spine.

9. Understanding the modulations of glycero-lysophospholipids in an elastase-induced murine emphysema model.

10. Apolipoprotein M bound sphingosine 1-phosphate suppresses NETosis through activating S1P1 and S1P4.

11. The Lysophospholipase PNPLA7 Controls Hepatic Choline and Methionine Metabolism.

12. Modulations of bioactive lipids and their receptors in postmortem Alzheimer's disease brains.

13. Sphingosine 1-phosphate lyase facilitates cancer progression through converting sphingolipids to glycerophospholipids.

14. Inhibition of autotaxin activity ameliorates neuropathic pain derived from lumbar spinal canal stenosis.

15. The Multiple Faces of the Marmot: Associations with the Plague, Hunting, and Cosmology in Mongolia.

16. Suppression of sphingosine 1-phosphate lyase retards the liver regeneration in mice after partial hepatectomy.

17. Identification of novel biomarkers of hepatocellular carcinoma by high-definition mass spectrometry: Ultrahigh-performance liquid chromatography quadrupole time-of-flight mass spectrometry and desorption electrospray ionization mass spectrometry imaging.

18. Possible involvement of PS-PLA1 and lysophosphatidylserine receptor (LPS1) in hepatocellular carcinoma.

19. Alteration of the lysophosphatidic acid and its precursor lysophosphatidylcholine levels in spinal cord stenosis: A study using a rat cauda equina compression model.

20. Genotypes of amyotrophic lateral sclerosis in Mongolia.

21. Lysophosphatidic acids and their substrate lysophospholipids in cerebrospinal fluid as objective biomarkers for evaluating the severity of lumbar spinal stenosis.

22. Lysophosphatidic acid is associated with neuropathic pain intensity in humans: An exploratory study.

23. Evidence Suggests Sphingosine 1-Phosphate Might Be Actively Generated, Degraded, and Transported to Extracellular Spaces With Increased S1P 2 and S1P 3 Expression in Colon Cancer.

24. Higher LPA2 and LPA6 mRNA Levels in Hepatocellular Carcinoma Are Associated with Poorer Differentiation, Microvascular Invasion and Earlier Recurrence with Higher Serum Autotaxin Levels.

25. Sphingosine kinase-1, S1P transporter spinster homolog 2 and S1P2 mRNA expressions are increased in liver with advanced fibrosis in human.

26. Multicenter study of device-associated infection rates in hospitals of Mongolia: Findings of the International Nosocomial Infection Control Consortium (INICC).

27. Increased mRNA Levels of Sphingosine Kinases and S1P Lyase and Reduced Levels of S1P Were Observed in Hepatocellular Carcinoma in Association with Poorer Differentiation and Earlier Recurrence.

29. Increased serum mitochondrial creatine kinase activity as a risk for hepatocarcinogenesis in chronic hepatitis C patients.

30. Increased serum autotaxin levels in hepatocellular carcinoma patients were caused by background liver fibrosis but not by carcinoma.

31. High ubiquitous mitochondrial creatine kinase expression in hepatocellular carcinoma denotes a poor prognosis with highly malignant potential.

32. Simultaneous Quantification of Sphingolipids in Small Quantities of Liver by LC-MS/MS.

33. Successive phosphorylation of p27(KIP1) protein at serine-10 and C terminus crucially controls its potency to inactivate Cdk2.

34. Cdc6 protein obstructs apoptosome assembly and consequent cell death by forming stable complexes with activated Apaf-1 molecules.

35. Cdc6 protein activates p27KIP1-bound Cdk2 protein only after the bound p27 protein undergoes C-terminal phosphorylation.

36. Mammalian target of rapamycin complex 1 signaling opposes the effects of anchorage loss, leading to activation of Cdk4 and Cdc6 stabilization.

37. Surgery in Mongolia.

Catalog

Books, media, physical & digital resources